What is the generic name?

BINIMETINIB

What is the Trade Name for BINIMETINIB?

MEKTOVI

What are the Indications for BINIMETINIB?

• 1 INDICATIONS AND USAGE MEKTOVI ¬Æ is indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test [see Dosage and Administration (2.1) ] . MEKTOVI is a kinase inhibitor indicated, in combination with encorafenib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-approved test. ( 1 , 2.1 )

References: https://open.fda.gov/